Partner Joseph Savage discusses the need for private equity firms to conduct comprehensive pre-acquisition diligence when investing in healthcare companies to help mitigate any potential FCA exposure.
Read the full article.
Related Content
- AlertMarch 15, 2024
In Continuing Efforts to Incentivize Self-Disclosures and Cooperation, DOJ Announces Pilot Program to Pay Criminal Whistleblowers
- InsightMarch 7, 2024
Developments in W&I Insurance in Asia
- InsightMarch 7, 2024
Q&A with TusPark’s Wei Meng on Life Sciences and Operational Real Estate
- AlertMarch 7, 2024
FTC and DOJ Launch New Cross-Government Inquiry on the Role of Private Equity in Healthcare
- AlertFebruary 28, 2024
FINRA Proposes to Add ‘Knowledgeable Employees’ to Category of Persons Who May Receive Projections and Targeted Returns Under Rule 2210
- AlertFebruary 28, 2024
Delaware Court of Chancery Invalidates Governance Rights in Stockholder Agreement
- InsightFebruary 26, 2024
Use of Equity Rollovers Continues to Rise Amid Market Uncertainty
- AlertFebruary 26, 2024
DOJ Renews Focus on Private Equity Amid Record False Claims Act Enforcement
- Press ReleaseMarch 14, 2024
Goodwin Advises EMZ Partners Portfolio Company FotoFinder on Acquisition Financing for DermLite
- Awards and RankingsMarch 14, 2024
Chambers Europe 2024 Recognizes Goodwin Across Germany, France, and the United Kingdom
- Press ReleaseMarch 14, 2024
Eurazeo signs an agreement to sell Peters Surgical to Advanced Medical Solutions Group plc.
- In the PressMarch 12, 2024
Frazier Healthcare Partners Completes Acquisition of RevSpring
- Press ReleaseMarch 12, 2024
Goodwin Advises Bencis on Acquisition Financing For eurorad Deutschland
- Press ReleaseMarch 7, 2024
LFPI invests in Montaner Pietrini Boissons
- In the PressMarch 6, 2024
Eidos Therapeutics Signs Exclusive License Agreement with Bayer
- Press ReleaseMarch 5, 2024
Armen Invests in Jolt Capital